Kaempferol binds with NSUN2 to mediate RNA 5-methylcytosine modification of BMP2 in osteogenic differentiation

PURPOSE: This study aimed to investigate the effects and underlying mechanism of kaempferol (Kae) on osteogenic differentiation through 5-methylcytosine (m5C) modification in bone metabolism. MATERIALS AND METHODS: . The effects of Kae (5, 10, and 20 μM) on osteogenic differentiation were evaluated. m5C levels in MC3T3-E1 cells were measured by m5C dot blot assay, and the expression of several m5C-related genes was detected. The binding between Kae and an m5C-related gene was examined, and the interaction between NSUN2 andBMP2 was assessed. To investigate the regulatory role of Kae in osteoporosis, an ovariectomy (OVX)-induced osteoporotic mouse model was established. RESULTS: , Kae alleviated OVX-induced osteoporosis by reducing bone loss. CONCLUSIONS: and ameliorates bone loss in OVX-induced osteoporotic mice. Kae binds to NSUN2 to mediate RNA m5C modification of BMP2 during osteogenic differentiation. Kae may be a promising therapeutic agent for osteoporosis.